We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current GALT market cap is 126.78M. The company's latest EPS is USD -0.7139 and P/E is -2.73.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -9M | -9.17M | -9.56M | -9.65M | -11.29M |
| Net Income | -9.18M | -14.04M | -10.06M | -11.5M | -12.44M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -13.44M | -23.44M | -30.18M | -38.35M | -38.07M |
| Net Income | -20.18M | -23.6M | -30.7M | -38.87M | -44.81M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 20.08M | 22.16M | 28.2M | 25.89M | 27.66M |
| Total Liabilities | 71.21M | 73.04M | 88.44M | 96.98M | 109.8M |
| Total Equity | -52.85M | -52.6M | -61.96M | -72.81M | -83.87M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 48.47M | 29.6M | 41.83M | 21.29M | 28.2M |
| Total Liabilities | 2.87M | 5.41M | 39.21M | 53.48M | 88.44M |
| Total Equity | 43.87M | 22.47M | 893k | -33.92M | -61.96M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -20.63M | -28.26M | -32.97M | -12.11M | -20.44M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 20M | 30.03M | 40.03M | 10M | 20.38M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.85M | -20.6M | -24.31M | -31.06M | -32.97M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 50.08M | 263k | 36.81M | 10M | 40.03M |
| Market Cap | 126.78M |
| Price to Earnings Ratio | -2.73 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.77 |
| Price to Book Ratio | -2.03 |
| Dividend Yield | - |
| Shares Outstanding | 62.76M |
| Average Volume (1 week) | 933.84k |
| Average Volume (1 Month) | 414.64k |
| 52 Week Change | 9.78% |
| 52 Week High | 4.2684 |
| 52 Week Low | 1.555 |
| Spread (Intraday) | 0.09 (4.43%) |
| Company Name | Galectin Therapeutics Inc |
| Address |
701 s carson st carson city, nevada 89701 |
| Website | https://www.galectintherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
